{
    "2021-11-20": [
        [
            {
                "time": "",
                "original_text": "云南海药行至十字路口：“股神”坐镇炒股仍巨亏 “蜜月期”后股东分歧加剧 投资失误",
                "features": {
                    "keywords": [
                        "云南白药",
                        "股神",
                        "陈发树",
                        "炒股巨亏",
                        "股东分歧",
                        "投资失误"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "云南白药炒股是否“股神”陈发树主导？大股东笔炒股背后是股东分歧明显",
                "features": {
                    "keywords": [
                        "云南白药",
                        "股神",
                        "陈发树",
                        "炒股",
                        "股东分歧"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}